Akebia Therapeutics (AKBA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKBA | LRMR | LYEL | ||
| Company | Akebia Therapeutics | Larimar Therapeutics Inc | Lyell Immunopharma Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.2200 | 3.22 | 13.05 | ||
| High | 1.2400 | 3.38 | 14.22 | ||
| Low | 1.1600 | 3.15 | 13.05 | ||
| Latest | 1.2400 | 3.26 | 14.05 | ||
| Change | +0.0300 | +0.05 | +1.08 | ||
| % Change | +2.48% | +1.56% | +8.33% | ||
| Volume | 4,198,600 | 2,443,900 | 219,500 | ||
| 20-Day Average Volume | 6,277,145 | 3,087,030 | 244,345 | ||
| Previous Close | 1.2100 | 3.21 | 12.97 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.0300 | 3.43 | 12.86 | ||
| 20-Day Raw Stochastic | 89.30% | 36.29% | 93.99% | ||
| 20-Day Relative Strength | 59.54 | 43.38 | 46.27 | ||
| Weighted Alpha | -58.00 | -42.58 | -11.35 | ||
| Today's Opinion | 56% Sell | 88% Sell | 88% Sell | ||
| Previous Opinion | 56% Sell | 88% Sell | 88% Sell | ||
| Last Month's Opinion | 100% Sell | 40% Sell | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +19.23% since 06/25/26 | -6.86% since 06/25/26 | +12.49% since 06/25/26 | ||
| Low | 1.0339 on 06/26/26 | 2.92 on 06/29/26 | 11.47 on 06/26/26 | ||
| High | 1.2900 on 06/30/26 | 3.66 on 06/26/26 | 14.22 on 07/02/26 | ||
| 1-Month | |||||
| %Chg | +32.42% since 06/02/26 | -1.21% since 06/02/26 | -5.64% since 06/02/26 | ||
| Low | 0.8227 on 06/10/26 | 2.92 on 06/29/26 | 11.47 on 06/26/26 | ||
| High | 1.2900 on 06/30/26 | 3.86 on 06/23/26 | 14.87 on 06/03/26 | ||
| 3-Month | |||||
| %Chg | -10.14% since 04/02/26 | -31.94% since 04/02/26 | -33.76% since 04/02/26 | ||
| Low | 0.8227 on 06/10/26 | 2.92 on 06/29/26 | 11.47 on 06/26/26 | ||
| High | 1.5950 on 04/15/26 | 5.35 on 04/08/26 | 25.25 on 04/14/26 | ||
| 6-Month | |||||
| %Chg | -20.00% since 01/02/26 | -6.05% since 01/02/26 | -51.52% since 01/02/26 | ||
| Low | 0.8227 on 06/10/26 | 2.71 on 02/23/26 | 11.47 on 06/26/26 | ||
| High | 1.6000 on 02/12/26 | 6.42 on 02/25/26 | 29.21 on 01/05/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 332,640 | 338,659 | 327,843 | ||
| Shares Outstanding, K | 268,258 | 103,883 | 23,334 | ||
| Annual Sales | 236,200,000 | 0 | 40,000 | ||
| Annual Net Income | -5,350,000 | -165,670,000 | -274,450,000 | ||
| Last Quarter Sales | 53,540,000 | 0 | 10,000 | ||
| Last Quarter Net Income | -9,050,000 | -29,610,000 | -140,720,000 | ||
| 60-Month Beta | 0.23 | 0.83 | -0.06 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.03 on 05/07/26 | -0.31 on 05/14/26 | -1.10 on 05/06/26 | ||
| Earnings Date | 08/06/26 | 08/13/26 | 08/11/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||